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More than half of the population in the United States of America drinks alcohol regularly.1
Thousands of deaths annually are linked to drug overdoses, and that number continues to rise.
Anesthesia professionals can expect to see patients in various levels of substance abuse, and
recovery, during their practice. This case study is presented to discuss a minimal narcotic
technique given in a patient with a history of prescription drug abuse, who had been substance
free since successfully been through a recovery program years prior.
Case Report
45 year old female, weighing 79.5kg presenting for a mastopexy and adbominoplasty. No
significant medical or surgical history other than recovery from abuse of prescription
medications. The patient requested to minimize potentially addictive medications. Prior to the
day of surgery an alternative anesthesia plan was agreed upon by all parties involved.
On the day of surgery, informed consent was signed for general anesthesia with endotracheal
intubation. 3mg midazolam was administered intravenously (IV) in the pre-operative holding
area. Once in the operating room, standard non-invasive monitors were applied, and oxygen was
administered at 10L/min via face mask. 1mg of additional midazolam IV was administered, and
an infusion of 1000mg IV acetaminophen started. A 4gm infusion of magnesium sulfate IV was
also given, and 20mg esmolol IV was titrated to control heart rate prior to endotracheal
intubation. After 3 minutes of preoxygenation, the patient was induced with 80mg IV lidocinane,
120mg IV propofol, 30mg IV ketamine, and 40mg IV rocuronium. A size 7 endotracheal tube
was place using a miller 3 for a direct laryngoscopy, with a grade 1 laryngoscopy view. Bilateral
breath sounds were auscultated, and the endotracheal tube was secured. The patient was easily
ventilated with pressure control mode of ventilation. 12mg IV dexamethasone was administered,
as well as additional boluses of 10mg IV esmolol when the patient’s heart rate and blood
pressure increased and sustained by greater than 10 points above baseline.
General anesthesia was maintained at 2% sevoflorane inspired concentration, with a mixture of
0.5L/min of oxygen and 1.5L/min of air. The patient was positioned supine, with the head of the
bed elevated 20 degrees, and the surgery was started. Narcotics were avoided throughout the
maintenance period of the case, with continued administration of 10mg IV esmolol at parameters

listed above. Additional 10mg doses of IV ketamine were also administered to a total of 100mg.
80mg of IV lidocaine was added to the IV fluids an hour after induction. Prior to emergence,
ondansetron 4mg was given for nausea prophylaxis, and 30mg IV ketorolac for pain control. The
only narcotic used was 0.5mg hydromorphone given prior to extubation. Total surgery and
anesthesia time was 328 minutes.
Postoperatively, the patient remained stable, with no complications. An additional 1000mg IV
acetaminophen was given in the post anesthesia care unit, but no other medications were
required before the patients discharge. The patent remained pleased with the anesthesia care and
alternative pain control on follow up assessment.
Discussion
The mechanisms of surgery activate the nociceptors, causing mainly somatic pain. This type of
pain is very localized and sharp in nature. Patients may have other types of baseline pain that an
anesthesia professional must also work to alleviate during the surgery. The noxious stimuli
caused by the physical mechanisms of surgery triggers a biochemical response, which includes
the release of the neurotransmitters bradykinin, serotonin, and substance P. Together these
substances generate an action potential, which is transduced into an electrical energy. This then
causes electrical signals to be transmitted to the central nervous system (CNS), so the signal can
be perceived by the brain.2
Opioids are a well-accepted part of most anesthesia plans, providing pain relief from the noxious
stimuli of surgery. These drugs work by binding mostly to opiate receptors in the CNS, though
there is evidence that there may be some peripheral sites as well. Supraspinal opioid receptors
work by increasing the movement of potassium ions, which inhibits the pain pathway2. While the
use of opioids has an undeniable place in surgical pain control, universal administration of high
dose opioids may not always be in the patient’s best interest. Millions of Americans are using
opioids for non-medical use, or recovering from the non-medical abuse of opioids. There are,
however, a growing number of alternative analgesics available that can be used in a multimodal
fashion to minimize, or even eliminate the need for narcotics.
Nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are a well-established
method for the management of mild to moderate pain, especially when the pain is the result of
inflammation. These medications work by inhibiting the action of cyclooxygenase. This prevents
the conversion of arachidonic acid to prostaglandins, which in turn limits how sensitized
peripheral nociceptors are to inflammatory mediators.2 Meta-analysis also shows that
administering acetaminophen in conjunction with an NSAID has combined effects over the use
of each drug separately.3
Located throughout the brain and spinal cord are N-methyl-D-aspartate (NMDA) receptors. The
excitatory neurotransmitter glutamate binds to this receptor, which continues the transmission of
painful stimuli impulses to the CNS, and it is thought that antagonization of these receptors can

prevent hyeperalgesia of the CNS.2,4 Two drugs that can achieve this are magnesium sulfate and
ketamine. Magnesium is a non-competitive NMDA receptor antagonist, which inhibits the
influx of intracellular calcium, and has been show to lower postoperative analgesia requirements.
Ketamine works on a different NMDA receptor site, and their use together may have an additive
effect on analgesia, even when lower doses of both are administered. Studies have shown that
patients who receive intraoperative magnesium and ketamine have a lower opioid consumption4.
Lidocaine is a commonly used local anesthetic, which works by blocking sodium channels and
may also work on the NMDA receptors. These effects have been reported to reduce
postoperative pain, which can reduce opioid consumption. Studies have been done, giving a
bolus of lidocaine, followed by an infusion, showing that there was a reduction in postoperative
analgesia requirements.5
The glucocorticosteroid, dexamethasone, is often used as an antiemetic. A meta-analysis has
shown that a dose of 0.1mg/kg or higher can reduce posoperative pain, resulting in a lower
narcotic requirement. Steroids have a known anti-inflammatory effect, which can aid in blocking
the electrical stimuli of surgical trauma being conducted to the nervous system.3, 6
Opioid induced hyperalgesia, is a documented occurrence. With this theory, the narcotics given
during surgery can cause a hyperalgesia in the postoperative phase. Pain causes a catecholamine
response in the body, which results in an increased blood pressure and heart rate. These signs
can be seen intraoperatively, and are normally treated with opioids.7 Esmolol has been used
intraoperatively, most often as an infusion. Studies show it has decreased the overall
requirement for anesthesia as well as narcotics. There was a decreased level of postoperative
pain reported, requiring lower levels of analgesics.8
Substance abuse is a serious problem that many people face, and can complicate the surgical
course of anesthesia. A multimodal approach to analgesia can offer an alternative to traditional
narcotic pain control, giving specific patient populations, such as those in recovering from
substance abuse, a better postoperative outcome.
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Minimal Narcotic Anesthetic for a Patient with History of Substance Abuse
Substance abuse, whether alcohol, illicit drugs, or non-medical use of prescription
medications has become an epidemic in the United States of America. According to the CDC,
more than half of the population drinks alcohol regularly. Drug use continues to rise, and causes
thousands of deaths every year (CDC, 2015). The problem is not only with those who are
currently abusing a substance, but also those struggling to remain in recovery. A 2014 study
reported that addicts who self-referred to a treatment center had a relapse rate of greater than
60%. High risk situations put this population at an even greater risk for relapse. The study
found that the situations most likely to cause a patient to turn back to substance abuse were
physical discomfort and unpleasant emotions, such as anxiety. These two particular high risk
situations can both of these can be associated with surgery. The perioperative period exposes
these patients to these high risk factors. Then a substance commonly abused substance,
narcotics, are administered intaoperatively, as well as postoperatively which continues into the
patients discharge with a prescription (Shafiei, et al, 2014). While any substance abuse, current
or past, can dramatically change an anesthesia professional’s patient care. Now there are many
options now to minimize the narcotic use, with the hope of helping to minimize the chance of
relapse in the patient who has had successful treatment for their addition.
Physical pain, a common trigger for drug relapse, is a component of all surgeries.
Surgical pain control is critical roles of the anesthesia professional. Somatic pain, which is sharp
and localized in nature, is commonly associated with surgery. Visceral pain is another pain that
can be associated with surgery, depending on the type of surgery being performed. This is a pain
caused by the distention of an organ capsule. Surgical pain is caused by the activation of
nociceptors by the physical trauma of the surgery. Patients may have other types of baseline
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pain, such as neuropathic, which is the abnormal processing of pain sensation. An anesthesia
professional may also need to alleviate this underlying pain during the surgery in addition to
surgical pain further complicating the plan of care. For pain to be sensed by the body, the
noxious stimuli caused by the physical mechanisms of surgery triggers a biochemical response,
which includes the release of the neurotransmitters bradykinin, serotonin, and substance P.
Together these substances generate an action potential, which is transduced into an electrical
energy. This then causes electrical signals to be transmitted to the CNS, so the signal can be
perceived by the brain (Nagelhout & Plaus, 2010).
Opioids are a well-accepted part of most anesthesia plans, providing pain relief from the
noxious stimuli of surgery. These drugs work by binding mostly to opiate receptors in the central
nervous system, though there is evidence that there may be some peripheral sites as well.
Supraspinal opioid receptors work by increasing the movement of potassium ions, which inhibits
the pain pathway (Nagelhout & Plaus, 2010). While the use of opioids has an undeniable place in
surgical pain control, universal administration of high dose opioids may not always be in the
patient’s best interest. Millions of Americans are using opioids for non-medical use, or
recovering from the non-medical abuse of opioids. However, there are a growing number of
alternative analgesics available that can be used in a multimodal fashion to minimize, or even
eliminate the need for narcotics (Gritsenko, et all, 2014).
Nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are a wellestablished method for the management of mild to moderate pain, especially when the pain is the
result of inflammation. There oral over-the-counter forms make them familiar, inexpensive, and
easily accessible by patients. The role of the common medications does not have to stop when
the patient enters the surgical suite, as they can be part of the multimodal treatment to minimize
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narcotic use both intraoperative and postoperatively. These medications work by inhibiting the
action of cyclooxygenase. This prevents the conversion of arachidonic acid to prostaglandins,
which in turn limits how sensitized peripheral nociceptors are to inflammatory mediators
(Nagelhout & Plaus, 2010). Ketorlac is a frequently used, and potent, NSAID during the
operative time period due to its ability to be administered intravenously. Acetaminophen is also
available in an intravenous (IV) form, and is a centrally acting analgesic. The exact mechanism
is unknown, but it is thought to inhibit central prostaglandin synthesis similarly to NSAIDs, and
elevate the pain threshold (Herring, et all, 2014). These two medications are also metabolized
differently in the body, as acetaminophen utilizes a hepatic route, where NSAID’s are cleared
from the body using the renal system. This allows them to be administered within close
proximity to each other, without the risk of patient harm from overdosing. Meta-analysis also
shows that administering acetaminophen in conjunction with an NSAID has combined effects
over the use of each drug separately (Zukowski, & Kotfis, 2012), providing the patient with an
improved level of pain control.
Another group of commonly used medications in the operative situation are N-methyl-Daspartate (NMDA) antagonists. Located throughout the brain and spinal cord are NMDA
receptors. The excitatory neurotransmitter glutamate binds to this receptor, which continues the
transmission of painful stimuli impulses to the CNS, and it is thought that antagonization of these
receptors can prevent hyeperalgesia of the CNS (Nagelhout & Plaus, 2010) Two drugs that can
antagonize this receptor, and achieve this are magnesium sulfate and ketamine. Ketamine is an
already well established drug in anesthesia practice. It is known for its analgesic properties as
well as its anesthetic ones. Many studies have demonstrated the ability of ketamine to reduce
perioperative opioid requirements (Zukowski, & Kotfis, 2012). One study even showed its
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effectiveness in decreasing opioid consumption in patients who had opioid tolerance (Loftus,
2014), possibly making it even more useful in situations where patients have a history of chronic
substance abuse. Magnesium is a non-competitive NMDA receptor antagonist that works on a
different NMDA receptor site than ketamine, which inhibits the influx of intracellular calcium,
and has been shown to lower postoperative analgesia requirements. A study monitoring
postoperative pain in patients having non-laproscopic abdominal surgery showed a significant
reduction in severe pain after an infusion of magnesium. These two drugs can be given together,
and studies have shown that patients who receive intraoperative magnesium and ketamine have a
lower opioid consumption (Jabbouar, et all, 2014).
Lidocaine is a commonly used local anesthetic, which works by blocking sodium
channels, and may also work on the NMDA receptors. Most commonly, it is used as an injection
near a nerve or by local infiltration by a surgeon, which can successfully decrease a patient’s
pain level by blocking pain transmission. It can also be administered systemically by an
intravenous infusion, which has been researched as a way to reduce a patient’s pain, therefore
decreasing narcotic requirement (Gritsenko, et all, 2014). While some studies have shown that
low dose lidocaine has a very limited effect on a patient’s postoperative pain level (Choi, et all,
2012), there are studies where doses of lidocaine have shown to reduce postoperative pain, and
opioid consumption. Studies have been done, giving a bolus of lidocaine, followed by an
infusion, showing that there was a reduction in postoperative analgesia requirements (Yon, et all,
2014).
The glucocorticosteroid, dexamethasone, is often used as an antiemetic intraoperatively,
but it has proven to be useful for relieving postoperative pain, too. A dose of 8mg has been
shown to help reduce pain level (Zukowski, & Kotfis, 2012). Also a meta-analysis has shown
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that a dose of 0.1mg/kg or higher can reduce postoperative pain, resulting a lower narcotic
requirement (De Oliveira, et all, 2011). A random, double blind study tested increasing the dose
from 8mg to 40mg, but did now show any significant change in postoperative pain. Steroids
have a known anti-inflammatory effect, which can aid in blocking the electrical stimuli of
surgical trauma being conducted to the nervous system (Zukowski, & Kotfis, 2012).
Pain causes a catecholamine response in the body, which results in an increased blood
pressure and heart rate. Opioids are a well-accepted method to decrease this response by
reducing the patient’s sensed pain. There are many side effects from the use of opioids, both
from short term and long term use. One of these side effects that can be seen, even from
intraoperative narcotic use, is opioid induced hyperalgesia, which can be seen in the
postoperative phase. Studies have been showing that the use of the short acting beta adrenergic
blocker, esmolol, can be used to control the sympathetic response to pain, and can actually
reduce the postoperative opioid requirement (Lóp ez-Álvarez, et all, 2012). The use of esmolol
for this purpose intraoperatively has commonly been as an infusion. In studies done, it has
decreased the overall requirement for narcotics, both intraoperatively and postoperatively
(Celebi, Cizmeci, & Canbay, 2014). These findings were consistent, even when compared to a
group that received remifentinil and ketamine intraoperatively (López-Álvarez, et all 2012).
The alternatives to a classic opioid anesthetic technique continue to grow, as does the
research behind them. A multimodal approach can treat a patient’s pain at various pathways and
receptors to provide consistent pain control for patients who may have a challenged
postoperative course as a result from a history of drug abuse. Substance abuse is a serious
problem many people face, and can complicate the surgical course of anesthesia. Utilizing this
multimodal and opioid sparing approach can present this specific patient population with the
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still providing adequate pain control.
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